Abstract
A higher risk of thrombosis has been described as a prominent feature of coronavirus disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis risk, prognostic implications, and anticoagulation effects in COVID-19. We included 37 studies from 4070 unique citations. Meta-analysis was performed when feasible. Coagulopathy and thrombotic events were frequent among patients with COVID-19 and further increased in those with more severe forms of the disease. We also present guidance on the prevention and management of thrombosis from a multidisciplinary panel of specialists from Mayo Clinic. The current certainty of evidence is generally very low and continues to evolve.
Original language | English (US) |
---|---|
Pages (from-to) | 2467-2486 |
Number of pages | 20 |
Journal | Mayo Clinic Proceedings |
Volume | 95 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2020 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020 Mayo Foundation for Medical Education and Research